APA (7th ed.) Citation

A, F., MA, M., D, M., AP, G., C, R., V, M., . . . M, M. (2020). Efficacy of the treatment with dapagliflozin and metformin compared to metformin monotherapy for weight loss in patients with class III obesity: A randomized controlled trial. Trials, 21(1), 186. https://doi.org/10.1186/s13063-020-4121-x

Chicago Style (17th ed.) Citation

A, Ferreira-Hermosillo, Molina-Ayala MA, Molina-Guerrero D, Garrido-Mendoza AP, Ramírez-Rentería C, Mendoza-Zubieta V, Espinosa E, and Mercado M. "Efficacy of the Treatment with Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss in Patients with Class III Obesity: A Randomized Controlled Trial." Trials 21, no. 1 (2020): 186. https://doi.org/10.1186/s13063-020-4121-x.

MLA (9th ed.) Citation

A, Ferreira-Hermosillo, et al. "Efficacy of the Treatment with Dapagliflozin and Metformin Compared to Metformin Monotherapy for Weight Loss in Patients with Class III Obesity: A Randomized Controlled Trial." Trials, vol. 21, no. 1, 2020, p. 186, https://doi.org/10.1186/s13063-020-4121-x.